1
|
Paik HJ, Kim SJ, Kim KS, Kim Y, Lee SK, Kang SH, Joon J, Youn HJ. Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age ≥ 70 years: A hospital based-registry study. BMC Cancer 2022; 22:1261. [PMID: 36471272 PMCID: PMC9720951 DOI: 10.1186/s12885-022-10295-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Accepted: 11/08/2022] [Indexed: 12/07/2022] Open
Abstract
BACKGROUND Women from Asian and western countries have vastly different ages of onset of breast cancer, with the disease tending to occur at an older age in the West. Through an investigation of the patterns of old-onset breast cancer (OBC) in Korean women, we aimed to identify the characteristics of Korean OBC and evaluate whether these patterns are changing in relation to increasing westernization. METHODS This study retrospectively evaluated 102,379 patients who underwent surgical treatment of primary breast cancer between January 1, 2000 and December 31, 2013 in Korea. We used hospital -based breast cancer registry and analyzed data from these patients using multiple linear regression analysis to compare the characteristics and chronologically changing patterns between OBC (70 years of age or older) and non-OBC (40-69 years of age) patients in Korea. RESULTS A total of 6% of the 102,379 patients had OBC. Overall, OBC had more favorable biological features, such as a higher incidence of luminal A subtype, than did non-OBC, except for a higher incidence rate of triple-negative breast cancer (TNBC). However, OBC also presented with a higher overall disease stage, including higher T and M stages. Although the incidence rates of both OBC and non-OBC have increased overtime, the relative proportion of OBC patients has slightly increased, whereas that of non-OBC has slightly decreased. The increase in the incidence of both OBC and non-OBC was primarily due to the luminal A subtype. CONCLUSIONS Based on a hospital-based registry, overall, Korean OBC had favorable biological features but showed a higher rate of TNBC and advanced cancer stages. The incidence trend of breast cancer in Korea is slowly shifting toward an older age at onset, largely due to the luminal A subtype. Our results may provide novel insights into OBC in Asia, and aid in the development of optimal management of the disease in Asia. TRIAL REGISTRATION Retrospectively registered.
Collapse
Affiliation(s)
- Hyun-June Paik
- grid.412591.a0000 0004 0442 9883Department of Surgery, Pusan National University Yangsan Hospital, Yangsan, South Korea
| | - Suk Jung Kim
- grid.411612.10000 0004 0470 5112Department of Radiology, Haeundae Paik Hospital, Inje University College of Medicine, Haeundae-ro 875, Haeundae-gu, Busan, 612-030 South Korea
| | - Ku Sang Kim
- grid.411145.40000 0004 0647 1110Department of Breast-Endocrine Surgery, Kosin University Gospel Hospital, Busan, South Korea
| | - Yongsuk Kim
- grid.411947.e0000 0004 0470 4224Department of Surgery, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Uijeongbu, South Korea
| | - Se Kyung Lee
- grid.414964.a0000 0001 0640 5613Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Seoul, South Korea
| | - Su Hwan Kang
- grid.413028.c0000 0001 0674 4447Department of Surgery, Yeungnam University College of Medicine, Daegu, South Korea
| | - Jeong Joon
- grid.15444.300000 0004 0470 5454Department of Surgery, College of Medicine, Yonsei University, Seoul, South Korea
| | - Hyun Jo Youn
- grid.411545.00000 0004 0470 4320Department of Surgery, Chonbuk National University Medical School, Jeonju, South Korea
| | | |
Collapse
|
2
|
Kangleon-Tan HL, Sim J, You JY, Lee ES, Lee H, Yang SM, Seong MK, Park EH, Nam SJ, Park MH, Lee S, Park WC, Kangleon RG, Dy CB, Bae SY, Jung SP. Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry. Ann Surg Treat Res 2022; 103:313-322. [PMID: 36601341 PMCID: PMC9763778 DOI: 10.4174/astr.2022.103.6.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Revised: 09/13/2022] [Accepted: 10/07/2022] [Indexed: 12/15/2022] Open
Abstract
Purpose Although adjuvant chemotherapy (CTx) is still recommended for high-risk patients with hormone receptor-positive and human epidermal receptor (HER)-2-negative breast cancer, recent studies found that selected patients with low disease burden may be spared from CTx and receive hormonal treatment (HT) alone. This study aims to evaluate the trends of treatment (CTx + HT vs. HT alone) in Korea and to assess the impact on overall survival (OS) according to treatment pattern. Methods The Korean Breast Cancer Society Registry was queried (2000 to 2018) for women with pT1-2N0-1 hormone receptor-positive and HER2-negative disease who underwent surgery and adjuvant systemic treatment (CTx and HT). Clinicopathologic factors, change in pattern of treatment over time, and OS for each treatment option were analyzed. Results A total of 40,938 women were included in the study; 20,880 (51.0%) received CTx + HT, while 20,058 (49.0%) received HT only. In recent years, there has been a steady increase in the use of HT alone, from 21.0% (2000) to 64.6% (2018). In Cox regression analysis, age, type of breast and axillary operations, T and N stages, body mass index, histologic grade, and presence of lymphovascular invasion were prognostic indicators for OS. There was no significant difference between CTx + HT and HT alone in terms of OS (P = 0.126). Conclusion Over the years, there has been a shift from CTx + HT to HT alone without a significant difference in OS. Therefore, HT alone could be a safe treatment option in selected patients, even those with T2N1 disease.
Collapse
Affiliation(s)
| | - Jongmin Sim
- Department of Pathology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | - Ji Young You
- Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | - Eun-Shin Lee
- Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | - Haemin Lee
- Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | - Sun Moon Yang
- Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | - Min-Ki Seong
- Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Korea
| | - Eun Hwa Park
- Department of Surgery, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea
| | - Seok Jin Nam
- Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Min Ho Park
- Department of Surgery, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea
| | - Seokwon Lee
- Department of Surgery and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
| | - Woo-Chan Park
- Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | | | - Crisostomo B. Dy
- Department of Surgery, Chong Hua Hospital-Cebu, Cebu City, Philippines
| | - Soo Youn Bae
- Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - Seung Pil Jung
- Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | | |
Collapse
|
3
|
Paik PS, Paik NS, Lee ES, Choi JE, Jeong J, Youn HJ, Yoon CI, Bae SY, Yoo TK, Society KBC. CORRIGENDUM: Correction of the first author’s affiliation. Low incidence of lymph node metastasis in patients with microinvasive breast cancer: a Korean nationwide study. Ann Surg Treat Res 2022; 103:312. [DOI: 10.4174/astr.2022.103.5.312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Affiliation(s)
- Pill Sun Paik
- Department of Surgery, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Seoul, Seoul, Korea
| | - Nam Sun Paik
- Department of Surgery, College of Medicine, Ewha Womans University, Seoul, Korea
| | - Eun Sook Lee
- Department of Surgery, Research Institute and Hospital, National Cancer Center, Goyang, Korea
| | - Jung Eun Choi
- Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea
| | - Joon Jeong
- Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Hyun Jo Youn
- Department of Surgery, Jeonbuk National University Medical School, Jeonju, Korea
| | - Chang Ik Yoon
- Department of Surgery, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Korea
| | - Soo Youn Bae
- Department of Surgery, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Korea
| | - Tae-Kyung Yoo
- Department of Surgery, Breast Cancer Center, Asan Medical Center, Seoul, Korea
| | - Korean Breast Cancer Society
- Department of Surgery, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Seoul, Seoul, Korea
| |
Collapse
|
4
|
Kim HJ, Kim HJ, Lee SB, Moon HG, Noh WC, Cho YU, Yoo Y, Ahn SH. A proposal for a new classification of T4 breast cancer as stage IIIC. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e11585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Hee Jeong Kim
- Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, South Korea
| | - Hwa Jung Kim
- Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Sae Byul Lee
- 1Division of Breast and Endocrine, Department of Surgery, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, South Korea
| | - Hyeong-Gon Moon
- Department of Surgery, Seoul National University Hospital, Seoul, South Korea
| | - Woo Chul Noh
- Division of Breast and Endocrine, Department of Surgery, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, South Korea
| | - Young Up Cho
- Department of Surgery, Inha University Hospital, Inha University College of Medicine, Incheon, Korea, Incheon, South Korea
| | - Youngbum Yoo
- Konkuk University Medical Center, School of Medicine Konkuk University, Seoul, South Korea
| | - Sei-Hyun Ahn
- University of Ulsan College of Medicine, Seoul, South Korea
| | | |
Collapse
|
5
|
Kang E, Park SK, Kim KS, Choi DH, Nam SJ, Paik NS, Lee JW, Lee MH, Kim SW, Society KBC. Communication with Family Members about Positive BRCA1/2 Genetic Test Results in Korean Hereditary Breast Cancer Families. ACTA ACUST UNITED AC 2011. [DOI: 10.5734/jgm.2011.8.2.105] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- Eunyoung Kang
- Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Sue K. Park
- Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
- Department of Biomedical Science, Seoul National University Graduate School, Seoul, Korea
- Cancer Research Institute, Seoul National University, Seoul, Korea
| | - Ku Sang Kim
- Department of Surgery, Ajou University School of Medicine, Suwon, Korea
| | - Doo Ho Choi
- Department of Radiation Oncology, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Seok-Jin Nam
- Department of Surgery, Sungkyunkwan University School of Medicine, Seoul, Korea
| | - Nam Sun Paik
- Department of Surgery, Ewha Womans’ University Medical Center, Seoul, Korea
| | - Jong Won Lee
- Department of Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea
| | - Min Hyuk Lee
- Department of Surgery, Soonchunhyang University Hospital, Seoul, Korea
| | - Sung-Won Kim
- Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
| | | |
Collapse
|